Total Payments
$34,756
2024 Payments
$1,660
Companies
25
Transactions
490
Medicare Patients
5,552
Medicare Billing
$3.9M
Payment Breakdown by Category
Other$21,224 (61.1%)
Consulting$6,000 (17.3%)
Food & Beverage$5,765 (16.6%)
Education$1,062 (3.1%)
Travel$690.08 (2.0%)
Gifts$15.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $21,224 | 28 | 61.1% |
| Consulting Fee | $6,000 | 3 | 17.3% |
| Food and Beverage | $5,765 | 441 | 16.6% |
| Education | $1,062 | 13 | 3.1% |
| Travel and Lodging | $690.08 | 4 | 2.0% |
| Gift | $15.00 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| EMD Serono, Inc. | $15,388 | 101 | $0 (2019) |
| Genentech USA, Inc. | $7,925 | 59 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $7,514 | 101 | $0 (2023) |
| Mallinckrodt Hospital Products Inc. | $596.77 | 21 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $535.55 | 13 | $0 (2024) |
| Celgene Corporation | $491.82 | 56 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $396.38 | 26 | $0 (2024) |
| Acorda Therapeutics, Inc | $359.48 | 21 | $0 (2022) |
| Biogen, Inc. | $312.61 | 18 | $0 (2024) |
| Mallinckrodt Enterprises LLC | $280.46 | 19 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,660 | 85 | Alexion Pharmaceuticals, Inc. ($452.73) |
| 2023 | $1,288 | 77 | Mallinckrodt Hospital Products Inc. ($273.08) |
| 2022 | $554.28 | 35 | Genentech USA, Inc. ($139.16) |
| 2021 | $418.19 | 30 | Genentech USA, Inc. ($193.13) |
| 2020 | $109.58 | 7 | Acorda Therapeutics, Inc ($56.27) |
| 2019 | $7,688 | 44 | Genentech USA, Inc. ($7,215) |
| 2018 | $8,212 | 115 | EMD Serono, Inc. ($7,297) |
| 2017 | $14,826 | 97 | EMD Serono, Inc. ($8,067) |
All Payment Transactions
490 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Genentech USA, Inc. | Ocrevus (Biological), Ocrevus Zunovo | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: Immunology | ||||||
| 12/18/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $28.83 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $6.66 | General |
| Category: Neuroscience | ||||||
| 12/09/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $6.61 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2024 | Genentech USA, Inc. | Ocrevus (Biological), Ocrevus Zunovo | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: Immunology | ||||||
| 11/25/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $4.03 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2024 | Genentech USA, Inc. | Ocrevus (Biological), Ocrevus Zunovo | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: Immunology | ||||||
| 11/14/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $14.20 | General |
| Category: Neuroscience | ||||||
| 11/13/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $30.84 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $11.18 | General |
| Category: Neurology | ||||||
| 11/12/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Education | In-kind items and services | $1.00 | General |
| Category: Rare Disease | ||||||
| 11/08/2024 | Merz Pharmaceuticals, LLC | INBRIJA (Drug) | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: Parkinson's Disease | ||||||
| 10/31/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $11.21 | General |
| Category: Neuroscience | ||||||
| 10/30/2024 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: Neurology | ||||||
| 10/24/2024 | Genentech USA, Inc. | Ocrevus (Biological), Ocrevus Zunovo | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: Immunology | ||||||
| 10/23/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $4.32 | General |
| Category: Neuroscience | ||||||
| 10/17/2024 | Alexion Pharmaceuticals, Inc. | — | Education | In-kind items and services | $100.00 | General |
| 10/17/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $10.02 | General |
| Category: Rare Disease | ||||||
| 10/17/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $7.45 | General |
| Category: Neuroscience | ||||||
| 10/15/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $31.92 | General |
| Category: IMMUNOLOGY | ||||||
| 10/14/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $11.97 | General |
| Category: Neuroscience | ||||||
| 09/25/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $12.86 | General |
| Category: Neuroscience | ||||||
| 09/19/2024 | Genentech USA, Inc. | Ocrevus (Biological), Ocrevus Zunovo | Food and Beverage | In-kind items and services | $24.33 | General |
| Category: Immunology | ||||||
| 09/19/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $8.52 | General |
| Category: NEUROSCIENCE | ||||||
| 09/19/2024 | Genentech USA, Inc. | Ocrevus (Biological), Ocrevus Zunovo | Food and Beverage | In-kind items and services | $1.35 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 1,192 | 24,994 | $3.4M | $1.2M |
| 2022 | 24 | 1,253 | 25,530 | $3.5M | $1.2M |
| 2021 | 28 | 1,643 | 27,220 | $3.8M | $1.3M |
| 2020 | 17 | 1,464 | 2,660 | $1.2M | $221,921 |
Total Patients
5,552
Total Services
80,404
Medicare Billing
$3.9M
Procedure Codes
91
All Medicare Procedures & Services
91 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J2350 | Injection, ocrelizumab, 1 mg | Office | 2023 | 21 | 22,800 | $2.5M | $1.0M | 40.5% |
| J0475 | Injection, baclofen, 10 mg | Office | 2023 | 12 | 294 | $109,956 | $38,138 | 34.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 218 | 268 | $148,740 | $23,576 | 15.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 294 | 333 | $127,206 | $18,868 | 14.8% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 125 | 188 | $84,976 | $13,590 | 16.0% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2023 | 65 | 67 | $49,781 | $6,610 | 13.3% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 31 | 74 | $50,246 | $6,369 | 12.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 50 | 50 | $37,050 | $5,765 | 15.6% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 28 | 28 | $32,816 | $4,199 | 12.8% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 28 | 28 | $27,524 | $3,755 | 13.6% |
| 62369 | Electronic analysis reprogramming and refill of spinal canal drug infusion pump | Office | 2023 | 12 | 52 | $30,264 | $3,131 | 10.3% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 31 | 143 | $21,307 | $2,793 | 13.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 36 | 36 | $17,856 | $2,672 | 15.0% |
| 95939 | Placement of skin electrodes and measurement of central motor stimulation in arms and legs | Facility | 2023 | 25 | 28 | $68,796 | $2,454 | 3.6% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 34 | 158 | $13,904 | $1,727 | 12.4% |
| 95938 | Placement of skin electrodes and measurement of stimulated sites on arms and legs | Facility | 2023 | 42 | 46 | $76,130 | $1,572 | 2.1% |
| 95861 | Needle measurement of electrical activity in arm or leg muscles, 2 extremities | Facility | 2023 | 19 | 21 | $18,081 | $1,254 | 6.9% |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | Office | 2023 | 31 | 195 | $3,900 | $845.51 | 21.7% |
| 95955 | Measurement of brain wave activity (eeg) outside the brain during surgery | Facility | 2023 | 19 | 19 | $16,682 | $737.10 | 4.4% |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | Office | 2023 | 34 | 101 | $1,010 | $77.45 | 7.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 12 | 13 | $78.00 | $76.44 | 98.0% |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | Office | 2023 | 25 | 52 | $260.00 | $52.05 | 20.0% |
| J2350 | Injection, ocrelizumab, 1 mg | Office | 2022 | 22 | 23,100 | $2.5M | $1.1M | 42.2% |
| J0475 | Injection, baclofen, 10 mg | Office | 2022 | 12 | 371 | $138,754 | $53,189 | 38.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 231 | 297 | $147,215 | $25,728 | 17.5% |
About Dr. David Gelber, M.D
Dr. David Gelber, M.D is a Neurology healthcare provider based in Springfield, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1669571113.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Gelber, M.D has received a total of $34,756 in payments from pharmaceutical and medical device companies, with $1,660 received in 2024. These payments were reported across 490 transactions from 25 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($21,224).
As a Medicare-enrolled provider, Gelber has provided services to 5,552 Medicare beneficiaries, totaling 80,404 services with total Medicare billing of $3.9M. Data is available for 4 years (2020–2023), covering 91 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Springfield, IL
- Active Since 09/21/2006
- Last Updated 05/22/2020
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1669571113
Products in Payments
- Rebif (Biological) $15,378
- OCREVUS (Biological) $7,562
- COPAXONE (Drug) $6,532
- ACTHAR (Biological) $877.23
- ZEPOSIA (Drug) $491.62
- Ocrevus (Biological) $346.45
- TYSABRI (Biological) $312.61
- KESIMPTA (Drug) $290.24
- ULTOMIRIS (Biological) $266.94
- INBRIJA (Drug) $250.25
- AJOVY (Drug) $248.27
- LEMTRADA (Drug) $190.71
- AMPYRA (Drug) $128.11
- UBRELVY (Drug) $122.43
- VYVGART (Drug) $111.08
- MAYZENT (Drug) $106.14
- QULIPTA (Drug) $88.49
- Briviact (Drug) $72.52
- SOLIRIS (Biological) $68.61
- BRIUMVI (Drug) $44.36
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Springfield
David Clark, Do, DO
Neurology — Payments: $1.1M
Neurology $1.1M
Raymond Englander, Md, MD
Neurology — Payments: $167,481
Neurology $167,481
Dr. Jenifer Zhai, Md, MD
Neurology — Payments: $121,314
Neurology $121,314
Cecile Becker, M.d, M.D
Neurology — Payments: $78,042
Neurology $78,042
Jennifer Lynch, Md, MD
Neurology — Payments: $73,454
Neurology $73,454
Jayant Acharya, Md, MD
Neurology — Payments: $56,046
Neurology $56,046